Okyo PharmaOKYO
13F holders, Q2 2024 (June 30)7holders +1
1new positions
0sold out
$1.20avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Barclays PLC ($1.1M), HSBC Holdings PLC ($20K) and Cerity Partners LLC ($15K).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 107,017 shares bought and 9,687 shares sold, net +97,330 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Barclays PLC | 0.00% | Add +12.3% | 961,000 | $1.1M |
| HSBC Holdings PLC | 0.00% | No change | 11,933 | $20K |
| Cerity Partners LLC | 0.00% | Reduce -3.8% | 12,812 | $15K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $15K |
| Susquehanna International Group, LLP | 0.00% | Reduce -45.2% | 11,123 | $14K |
| UBS Group AG | 0.00% | New | 1,904 | $2K |
| Continuum Advisory, LLC | 0.00% | No change | 50 | $60 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.